ContraFect Corp. Company Profile (NASDAQ:CFRX)

About ContraFect Corp.

ContraFect Corp. logo

Industry, Sector and Symbol:
  • Sector: Medical
  • Industry: Biotechnology
  • Sub-Industry: N/A
  • Exchange: NASDAQ
  • Symbol: CFRX
  • CUSIP:
Key Metrics:
  • Previous Close: $2.27
  • 50 Day Moving Average: $2.41
  • 200 Day Moving Average: $3.01
  • 52-Week Range: $2.10 - $5.35
  • Trailing P/E Ratio: N/A
  • Foreward P/E Ratio: -2.55
  • P/E Growth: 0.00
  • Market Cap: $94.29M
  • Outstanding Shares: 41,539,000
  • Beta: -1.14
Additional Links:
Companies Related to ContraFect Corp.:

Analyst Ratings

Consensus Ratings for ContraFect Corp. (NASDAQ:CFRX) (?)
Ratings Breakdown: 2 Hold Ratings, 1 Buy Rating
Consensus Rating:Hold (Score: 2.33)
Consensus Price Target: $5.15 (126.87% upside)

Analysts' Ratings History for ContraFect Corp. (NASDAQ:CFRX)
Show:
DateFirmActionRatingPrice TargetDetails
8/9/2016Maxim GroupReiterated RatingHoldView Rating Details
7/28/2016Piper Jaffray Cos.Initiated CoverageOverweightView Rating Details
5/10/2016Roth CapitalDowngradeBuy -> Neutral$4.00 -> $3.30View Rating Details
(Data available from 8/31/2014 forward)

Earnings

Earnings History for ContraFect Corp. (NASDAQ:CFRX)
DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallDetails
11/10/2016        
8/9/2016Q216($0.27)($0.35)ViewN/AView Earnings Details
5/10/2016($0.25)($0.32)ViewN/AView Earnings Details
3/15/2016Q415($0.23)($0.28)ViewN/AView Earnings Details
8/13/2015($0.27)($0.33)ViewN/AView Earnings Details
5/15/2015($0.23)($0.24)ViewN/AView Earnings Details
4/7/2015($0.23)($0.23)ViewN/AView Earnings Details
11/14/2014($0.15)($1.22)ViewN/AView Earnings Details
(Data available from 1/1/2011 forward)

Estimates

Earnings Estimates for ContraFect Corp. (NASDAQ:CFRX)
Current Year EPS Consensus Estimate: $-0.99 EPS
Next Year EPS Consensus Estimate: $-0.89 EPS
QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q1 20162($0.26)($0.23)($0.25)
Q2 20162($0.25)($0.23)($0.24)
Q3 20162($0.28)($0.22)($0.25)
Q4 20162($0.27)($0.25)($0.26)
(Data provided by Zacks Investment Research)

Dividends

Dividend History for ContraFect Corp. (NASDAQ:CFRX)
No dividend announcements for this company have been tracked by MarketBeat.com

Insider Trades

Insider Trading History for ContraFect Corp. (NASDAQ:CFRX)
Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails
7/27/2016Steven C GilmanCEOBuy20,000$2.48$49,600.00View SEC Filing  
11/17/2015Daniel CoutoSVPSell2,872$3.81$10,942.32View SEC Filing  
11/3/2015Daniel CoutoSVPSell2,867$4.23$12,127.41View SEC Filing  
10/20/2015Daniel CoutoSVPSell2,867$4.48$12,844.16View SEC Filing  
10/6/2015Daniel CoutoSVPSell2,867$4.11$11,783.37View SEC Filing  
9/22/2015Daniel CoutoSVPSell2,867$4.76$13,646.92View SEC Filing  
9/8/2015Daniel CoutoSVPSell2,867$4.90$14,048.30View SEC Filing  
3/2/2015Julia P GregoryCEOBuy11,778$4.61$54,296.58View SEC Filing  
(Data available from 1/1/2013 forward)

Headlines

Latest Headlines for ContraFect Corp. (NASDAQ:CFRX)
DateHeadline
finance.yahoo.com logoCFRX: CF-301 Phase 2 Study in Bacteremia to Initiate in 4Q16 (NASDAQ:CFRX)
finance.yahoo.com - August 11 at 4:16 PM
marketwired.com logoContraFect Announces Second Quarter 2016 Results (NASDAQ:CFRX)
www.marketwired.com - August 9 at 12:01 PM
sg.finance.yahoo.com logoContraFect reports 2Q loss (NASDAQ:CFRX)
sg.finance.yahoo.com - August 9 at 12:01 PM
biz.yahoo.com logoCONTRAFECT CORP Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements and Exhibits (NASDAQ:CFRX)
biz.yahoo.com - August 9 at 12:01 PM
publicnow.com logoContraFect Receives Designation as a Small and Medium Enterprise by the European Medicines Agency (NASDAQ:CFRX)
www.publicnow.com - August 4 at 12:37 PM
biz.yahoo.com logoCONTRAFECT CORP Files SEC form 8-K, Entry into a Material Definitive Agreement, Other Events, Financial Statements an (NASDAQ:CFRX)
biz.yahoo.com - July 27 at 9:31 AM
streetinsider.com logoContraFect (CFRX) Prices 14M Common Stock, Warrants Offering for Proceeds of ~$35M (NASDAQ:CFRX)
www.streetinsider.com - July 22 at 4:12 PM
hotstocked.com logoContraFect Corp (NASDAQ:CFRX) Loses Ground On New Stock Offering (NASDAQ:CFRX)
www.hotstocked.com - July 22 at 4:12 PM
finance.yahoo.com logoCFRX: Company Raises $35 Million; Steven Gilman Appointed as CEO (NASDAQ:CFRX)
finance.yahoo.com - July 22 at 2:20 PM
finance.yahoo.com logoContraFect downgraded by Maxim Group (NASDAQ:CFRX)
finance.yahoo.com - July 22 at 11:51 AM
publicnow.com logoContraFect Corporation Prices $35 Million Public Offering of Common Stock and Warrants (NASDAQ:CFRX)
www.publicnow.com - July 22 at 10:18 AM
biz.yahoo.com logoCONTRAFECT CORP Files SEC form 8-K, Termination of a Material Definitive Agreement, Change in Directors or Principal (NASDAQ:CFRX)
biz.yahoo.com - July 21 at 5:30 PM
finance.yahoo.com logoContraFect Corporation Names Steven C. Gilman, PhD Chief Executive Officer (NASDAQ:CFRX)
finance.yahoo.com - July 21 at 5:29 PM
finance.yahoo.com logoCFRX: New PK/PD and Microbiologic Data Presented on CF-301 (NASDAQ:CFRX)
finance.yahoo.com - June 27 at 2:30 PM
biz.yahoo.com logoCONTRAFECT CORP Files SEC form 8-K, Other Events, Financial Statements and Exhibits (NASDAQ:CFRX)
biz.yahoo.com - June 27 at 6:10 AM
publicnow.com logoContraFect Presents New CF-301 Data at ASM Microbe 2016 (NASDAQ:CFRX)
www.publicnow.com - June 21 at 7:29 AM
finance.yahoo.com logo7:01 am ContraFect announces 3 presentations of new data on CF-301 at ASM 2016 (NASDAQ:CFRX)
finance.yahoo.com - June 21 at 7:01 AM
capitalcube.com logoContraFect Corp. :CFRX-US: Earnings Analysis: Q1, 2016 By the Numbers : June 10, 2016 (NASDAQ:CFRX)
www.capitalcube.com - June 10 at 5:04 PM
publicnow.com logoContraFect Announces Presentation of Data at ASM Microbe 2016 (NASDAQ:CFRX)
www.publicnow.com - June 8 at 7:08 AM
publicnow.com logoContraFect to Present at Jefferies 2016 Healthcare Conference (NASDAQ:CFRX)
www.publicnow.com - June 1 at 7:23 AM
finance.yahoo.com logoCFRX: Phase 2 Trial of CF-301 in Bacteremia Patients to Commence in 4Q16 (NASDAQ:CFRX)
finance.yahoo.com - May 17 at 12:45 PM
biz.yahoo.com logoCONTRAFECT CORP Files SEC form 8-K, Amendments to Articles of Inc. or Bylaws; Change in Fiscal Year, Submission of Ma (NASDAQ:CFRX)
biz.yahoo.com - May 10 at 4:15 PM
publicnow.com logoContraFect Announces First Quarter 2016 Results (NASDAQ:CFRX)
www.publicnow.com - May 10 at 7:28 AM
biz.yahoo.com logoQ1 2016 ContraFect Corp Earnings Release - Time Not Supplied (NASDAQ:CFRX)
biz.yahoo.com - May 10 at 7:07 AM
publicnow.com logoContraFect Corporation to Announce First Quarter 2016 Results on May 10, 2016 (NASDAQ:CFRX)
www.publicnow.com - May 3 at 7:10 AM
finance.yahoo.com logoCFRX: CF-301 Phase 1 Results Presented at ECCMID Conference (NASDAQ:CFRX)
finance.yahoo.com - April 12 at 1:35 PM
biz.yahoo.com logoCONTRAFECT CORP Files SEC form 8-K, Change in Directors or Principal Officers (NASDAQ:CFRX)
biz.yahoo.com - April 12 at 6:03 AM
publicnow.com logoKeryx Biopharmaceuticals Announces New Appointments and Changes to its Board of Directors (NASDAQ:CFRX)
www.publicnow.com - April 1 at 8:46 AM
publicnow.com logoKeryx Biopharmaceuticals Announces New Appointments and Changes to its Board of Directors (NASDAQ:CFRX)
www.publicnow.com - April 1 at 8:46 AM
publicnow.com logoContraFect to Present CF-301 Phase 1 Trial Data at the 26th ECCMID Conference (NASDAQ:CFRX)
www.publicnow.com - March 29 at 7:24 AM
publicnow.com logoContraFect to Present CF-301 Phase 1 Trial Data at the 26th ECCMID Conference (NASDAQ:CFRX)
www.publicnow.com - March 29 at 7:24 AM
News IconStocks With High Analyst Interest: The Spectranetics Corporation (NASDAQ:SPNC), Euronet Worldwide, Inc. (NASDAQ ... - RiversideGazette.com (NASDAQ:CFRX)
www.riversidegazette.com - February 26 at 2:15 PM
News IconChanges To Broker Targets On ContraFect Corporation (CFRX) - Share Trading News (NASDAQ:CFRX)
www.sharetrading.news - February 26 at 2:15 PM
finance.yahoo.com logoContraFect to Present at 18th Annual BIO CEO and Investor Conference (NASDAQ:CFRX)
finance.yahoo.com - February 2 at 7:00 AM
biz.yahoo.com logoCONTRAFECT CORP Files SEC form 8-K, Entry into a Material Definitive Agreement, Financial Statements and Exhibits (NASDAQ:CFRX)
biz.yahoo.com - January 20 at 5:26 PM
noodls.com logoContraFect to Present at 8th Annual Biotech Showcase Conference (NASDAQ:CFRX)
www.noodls.com - January 5 at 7:38 AM
finance.yahoo.com logoCFRX: Phase 1 Study of CF-301 Complete with No Clinical Adverse Safety Signals Found; Increasing PT to $12 (NASDAQ:CFRX)
finance.yahoo.com - December 16 at 4:30 PM
noodls.com logoContraFect Corporation Concludes Phase 1 Study of CF-301 (NASDAQ:CFRX)
www.noodls.com - December 15 at 7:16 AM
finance.yahoo.com logoCONTRAFECT CORP Financials (NASDAQ:CFRX)
finance.yahoo.com - December 8 at 1:17 PM
noodls.com logoContraFect to Present at 27th Annual Piper Jaffray Healthcare Conference (NASDAQ:CFRX)
www.noodls.com - November 30 at 4:55 PM
finance.yahoo.com logoCFRX: Warrant Exercise Brings in $9.6 Million; Data From Phase 1 Study of CF-301 in 1H2016… (NASDAQ:CFRX)
finance.yahoo.com - November 18 at 2:00 PM
sg.finance.yahoo.com logoContraFect reports 3Q loss (NASDAQ:CFRX)
sg.finance.yahoo.com - November 12 at 6:45 PM
biz.yahoo.com logoCONTRAFECT CORP Files SEC form 10-Q, Quarterly Report (NASDAQ:CFRX)
biz.yahoo.com - November 12 at 6:23 PM
noodls.com logoContraFect Corporation Announces Third Quarter 2015 Financial and Operating Results (NASDAQ:CFRX)
www.noodls.com - November 12 at 6:16 PM

Social

ContraFect Corp. (NASDAQ:CFRX) Chart for Wednesday, August, 31, 2016


Last Updated on 8/31/2016 by MarketBeat.com Staff